Form D Explorer

Inspect source fieldsReport a record issue

Form D — Qualigen Therapeutics, Inc.

0001641172-25-023575 · filed Aug 13, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$4,500,000
Reported amount sold
$4,500,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Qualigen Therapeutics, Inc.
CIK
1460702
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
5857 OWENS AVENUE
CARLSBAD, California 92008
Phone
(760) 452-8111

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗